A
Andrew D. Huber
Researcher at University of Missouri
Publications - 28
Citations - 559
Andrew D. Huber is an academic researcher from University of Missouri. The author has contributed to research in topics: Reverse transcriptase & RNase H. The author has an hindex of 13, co-authored 21 publications receiving 401 citations.
Papers
More filters
Journal ArticleDOI
4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) Inhibits HIV-1 Reverse Transcriptase with Multiple Mechanisms
Eleftherios Michailidis,Andrew D. Huber,Emily M. Ryan,Yee Tsuey Ong,Maxwell D. Leslie,Kayla B. Matzek,Kamalendra Singh,Bruno Marchand,Ariel N. Hagedorn,Karen A. Kirby,Lisa C. Rohan,Eiichi Kodama,Hiroaki Mitsuya,Hiroaki Mitsuya,Michael A. Parniak,Stefan G. Sarafianos +15 more
TL;DR: The context of template sequence defines the relative contribution of each mechanism and affects the affinity of EFdA-MP for potential incorporation sites, explaining in part the lack of antagonism between EFd
Journal ArticleDOI
Multiplex single-cell visualization of nucleic acids and protein during HIV infection.
Maritza Puray-Chavez,Philip R. Tedbury,Philip R. Tedbury,Andrew D. Huber,Obiaara B. Ukah,Vincent Yapo,Dandan Liu,Juan Ji,Jennifer J. Wolf,Alan Engelman,Stefan G. Sarafianos +10 more
TL;DR: A branched DNA in situ hybridization method for direct single-cell visualization of HIV DNA, RNA, and protein, which can be used to simultaneously detect multiple viral nucleic acid intermediates, characterize the effects of host factors or drugs on steps of the HIV life cycle, or its reactivation from the latent state, thus facilitating the development of antivirals and latency reactivating agents.
Journal ArticleDOI
Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H.
Jayakanth Kankanala,Karen A. Kirby,Andrew D. Huber,Mary C. Casey,Daniel J. Wilson,Stefan G. Sarafianos,Zhengqiang Wang +6 more
TL;DR: The design, synthesis and biological evaluation of a novel N-hydroxy thienopyrimidine-2,3-dione chemotype (11) which potently and selectively inhibited RNase H with considerable potency against HIV-1 in cell culture is reported.
Journal ArticleDOI
3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.
Bulan Wu,Jing Tang,Daniel J. Wilson,Andrew D. Huber,Mary C. Casey,Juan Ji,Jayakanth Kankanala,Jiashu Xie,Stefan G. Sarafianos,Zhengqiang Wang +9 more
TL;DR: In vitro ADME assays demonstrated that this novel chemotype possesses largely favorable physicochemical properties suitable for further development, and biochemical testing and molecular modeling strongly corroborate the inhibition of INST as the antiviral mechanism of action.
Journal ArticleDOI
Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity
Sanjeev Kumar V. Vernekar,Jing Tang,Bulan Wu,Andrew D. Huber,Mary C. Casey,Nataliya S. Myshakina,Daniel J. Wilson,Jayakanth Kankanala,Karen A. Kirby,Michael A. Parniak,Stefan G. Sarafianos,Zhengqiang Wang +11 more
TL;DR: A critical redesign of the HPD chemotype featuring an additional wing at the C5 position that led to drastically improved RNase H inhibition and significant antiviral activity is reported.